Pierre Sesques
Pierre-la-treiche, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.
Journal: British journal of haematology
Published: May 05, 2026
Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an international survey on behalf of the EBMT lymphoma working party.
Journal: Bone marrow transplantation
Published: April 12, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.
Journal: Journal of hematology & oncology
Published: April 01, 2026
Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 25, 2026
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Journal: Bone marrow transplantation
Published: March 02, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
Journal: HemaSphere
Published: December 05, 2025
Pharmacist-led multidisciplinary care and its clinical impact on haematology patients receiving intravenous immuno-chemotherapy.
Journal: Annales pharmaceutiques francaises
Published: December 04, 2025
Last Updated: 09/26/2026